论文部分内容阅读
本文的资料主要来自美国国立变态反应与传染病研究所水痘疫苗协作研究组于1980～1989年的研究结果。这些研究主要针对水痘减毒活疫苗对高危人群(处于缓解期的白血病患儿和健康成人)的效力。同时,为
The data in this paper are mainly from the research results of the Cooperative Study Group on Chickenpox Vaccine in the National Institute of Allergy and Infectious Diseases from 1980 to 1989. These studies focused on the efficacy of live attenuated varicella vaccine against high-risk populations (children with leukemia and healthy adults in remission). At the same time,